SISTEMAS GENOMICOS. S.L.
Spain ES-MF-000022949 Last updated 17 Sep 2026
Is this your brand? Sign in to claim this brand
- Devices
- 104
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
Oto-GeneSGKit X 48 reacciones Ref LV4096
Genesystems© – G-PRECON Ref LV4826
Neuro-GeneSGKit Neuropatia 12 reacciones Ref LV3884
NIPT-GeneSGKit CE-IVD 48 Reacciones Ref LV3737
OncoPlus-GeneSGKit X 12 reacciones Ref LV4279
Inmunodeficiencias-GeneSGKit X 48 reacciones Ref LV3918
Neuro-GeneSGKit TMovDemen 12 reacciones Ref LV3169
COVID-19 PCR Fast CE-IVD Tubo 96 Reacciones Ref LV4372
Dislipidemias-GeneSGKit 12 reacciones Ref LV3367
MLD-GeneSGKit 12 reacciones Ref LV4485
Neuro-GeneSGKit Paraplejia 12 reacciones Ref LV3479
OncoFFPE-GeneSGKit Mamma 12 reacciones Ref LV4440
Epilepsias-GeneSGKit X 12 reacciones Ref LV4037
Mitocondriales-GeneSGKit X 48 reacciones Ref LV4098
Genesystems G-NIPT Ref LV4825
Agile-NIPT for MGI CE-IVD 48 Reacciones. Ref LV4615
Glucogenosis-GeneSGKit X 48 reacciones Ref LV4088
Cardio-GeneSGKit DMM 12 reacciones Ref LV3461
Onco-GeneSGKit Mamma X 48 reacciones Ref LV4085
Oto-GeneSGKit 12 reacciones Ref LV3910
Mitocondriales-GeneSGKit X 12 reacciones Ref LV4097
MainTumorSolution-GeneSGKit 12 reacciones Ref LV4582
Glucogenosis-GeneSGKit 12 reacciones Ref LV3374
OncoPlus-GeneSGKit 48 reacciones Ref LV4221
Dislipidemias-GeneSGKit X 12 reacciones Ref LV4041
Osteo-GeneSGKit X 48 reacciones Ref LV3915
Osteo-GeneSGKit DensidadOsea 12 reacciones Ref LV3361
hvNIPT-GeneSGKit CE-IVD 48 Reacciones Ref LV4614
NIPT-GeneSGKit CE-IVD Advanced 48 Reacciones Ref LV3851
Neuro-GeneSGKit X 12 reacciones Ref LV3874
Onco-GeneSGKit X 12 reacciones Ref LV3873
HubExome Focus Panel-GeneSGKit 48 reacciones Ref LV4617
MyeloidNeoplasm-GeneSGKit 12 reacciones Ref LV3832
Glucogenosis-GeneSGKit X 12 reacciones Ref LV4089
Osteo-GeneSGKit OstArticular 12 reacciones Ref LV3523
Genesystems© Genebytes Ref LV4827
Inmunodeficiencias-GeneSGKit 48 reacciones Ref LV4223
Osteo-GeneSGKit X 12 reacciones Ref LV3875
Oto-GeneSGKit X 12 reacciones Ref LV4095
Showing 1-50 of 104
What SISTEMAS GENOMICOS. S.L. makes
Sistemas Genómicos S.L. manufactures molecular diagnostic kits for genetic and infectious disease testing, including PCR-based assays for COVID-19 detection (singleplex and multiplex formats), hereditary and neurological disorders (e.g., neuropathies, dementia, and metabolic diseases), and immunodeficiencies. Their product line also covers genetic screening for dyslipidemias, metabolic conditions like MLD, and preconception carrier testing. All kits are designed for laboratory use with specified reaction volumes (e.g., 12 or 48 reactions per kit).
The company’s devices fall under Class C medical devices and In Vitro Diagnostic Medical Devices (IVD) regulated under Annex II List B and General IVD categories, with some products marked CE-IVD. Their products are registered in the EUDAMED database, adhering to European Union regulatory requirements. The manufacturer is based in Spain.
Frequently asked questions
What types of medical devices does Sistemas Genómicos S.L. manufacture?
Sistemas Genómicos S.L. specializes in molecular diagnostic kits used for genetic and infectious disease testing. Their product line includes PCR-based assays for COVID-19 detection (both singleplex and multiplex formats), hereditary and neurological conditions (such as neuropathies, dementia, and metabolic disorders), immunodeficiencies, and genetic screening for conditions like dyslipidemias and metabolic diseases. These kits are designed for laboratory use and cover applications like preconception carrier testing and targeted genetic analysis.
Where is Sistemas Genómicos S.L. based, and what regulatory registries list its devices?
Sistemas Genómicos S.L. is based in Spain. Their devices are registered in the EUDAMED database, which is the European Union’s central registry for medical devices. This registry ensures compliance with EU regulatory requirements for devices marketed within the European Economic Area.
How are the devices manufactured by Sistemas Genómicos S.L. classified under EU regulations?
The devices produced by Sistemas Genómicos S.L. fall under Class C medical devices, which includes In Vitro Diagnostic (IVD) devices regulated under Annex II List B and the General IVD category. Some of their products are marked as CE-IVD, indicating conformity with EU In Vitro Diagnostic Device Regulations. Classification depends on factors like the intended use, risk level, and potential health impact of the test results.
What kinds of tests do the molecular diagnostic kits from Sistemas Genómicos S.L. perform?
The kits from Sistemas Genómicos S.L. perform a range of molecular diagnostics, including genetic mutation analysis for hereditary and neurological disorders (e.g., neuropathies, dementia, and metabolic diseases like MLD), preconception carrier screening (e.g., immunodeficiencies), dyslipidemia genetic testing, and infectious disease detection (e.g., COVID-19 via PCR-based assays in singleplex or multiplex formats). Each kit is designed for specific reaction volumes (e.g., 12 or 48 reactions) and laboratory use.
Why are some of the devices listed as CE-IVD, and what does that signify?
The CE-IVD marking on certain devices signifies that they have undergone a conformity assessment process under EU In Vitro Diagnostic Regulation (IVDR) and meet the required safety, performance, and quality standards for In Vitro Diagnostic Medical Devices. This marking indicates compliance with EU regulations, allowing the device to be legally marketed and used within the European Union. Not all devices require this marking, as classification depends on risk level and intended use.
Information
- Country
- Spain
- Address
- 6, C/ RONDA MARCONI, PATERNA, Spain
- [email protected]
- Phone
- +34 961 366 150
- PRRC contact
- ALEJANDRO VILLALBA
- EUDAMED SRN
- ES-MF-000022949